A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of Botulax Versus Botox in Treatment of Post Stroke Upper Limb Spasticity

Trial Profile

A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of Botulax Versus Botox in Treatment of Post Stroke Upper Limb Spasticity

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Sep 2016

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Muscle spasticity; Stroke
  • Focus Therapeutic Use
  • Sponsors Hugel
  • Most Recent Events

    • 13 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top